CRIS
CurisยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CRIS Profile
Curis, Inc.
A biotechnology company that developing innovative therapeutics for the treatment of cancer
128 Spring Street, Building C - Suite 500, Lexington, Massachusetts, 02421
--
Curis, Inc., was incorporated as a Delaware corporation in February 2000. The company is a biotechnology company focused on the development of emavusertib, an oral, small-molecule inhibitor of the interleukin -1 receptor-associated kinase.
